Compare · BCHT vs DHR
BCHT vs DHR
Side-by-side comparison of Birchtech Corp. (BCHT) and Danaher Corporation (DHR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BCHT and DHR operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $162.74B, about 5112.8x BCHT ($31.8M).
- Over the past year, BCHT is down 49.4% and DHR is up 9.5% - DHR leads by 58.9 points.
- DHR has been more active in the news (12 items in the past 4 weeks vs 2 for BCHT).
- DHR has more recent analyst coverage (25 ratings vs 0 for BCHT).
- Company
- Birchtech Corp.
- Danaher Corporation
- Price
- $1.21-8.68%
- $229.01-1.05%
- Market cap
- $31.8M
- $162.74B
- 1M return
- -24.38%
- +7.76%
- 1Y return
- -49.37%
- +9.51%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- AMEX
- NYSE
- IPO
- 2026
- News (4w)
- 2
- 12
- Recent ratings
- 0
- 25
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest BCHT
- Birchtech Appoints Charlie Cooper as Business Development Manager, Strengthening Its Commitment to Rural and Small Water Systems
- Birchtech to Participate in Upcoming Investor Conferences
- Gabelli To Host 4th Annual PFAS Symposium
- Birchtech to Participate in Upcoming Investor Conferences
- Birchtech Announces Commencement of Share Repurchase Program
- Birchtech Reaches Agreement in Principle for Strategic Acquisition of Specialty Activated Carbon Company
- Gabelli To Host 4th Annual PFAS Symposium
- SEC Form 10-Q filed by Birchtech Corp.
- Birchtech Reports Second Quarter 2026 Financial Results
- Birchtech Announces Results of Voting from Annual Meeting of Stockholders
Latest DHR
- SEC Form 3 filed by Danaher Corporation
- SEC Form 3 filed by Danaher Corporation
- SEC Form 4 filed by Danaher Corporation
- SEC Form 4 filed by Danaher Corporation
- Danaher Collaborates with NVIDIA to Advance Autonomous Science
- SEC Form 8-K filed by Danaher Corporation
- Danaher Announces Appointments of Daniel Comas and Robert Hershberg to Board of Directors
- Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab
- New insider Moler Heathre T claimed ownership of 5,356 shares (SEC Form 3)
- New insider Muppaneni Shashanka claimed ownership of 5,901 shares (SEC Form 3)